We reported yesterday that Qihoo partnered with Jike.com to hook to the drug database of China’s State Food and Drug Administration in an aim help people discern legitimate drugs from the fake ones. It seems that Baidu is also to follow suit to partner up directly with the State FDA to get access to its drug database as well, according to unconfirmed rumor.

The move apparently is to give a hard blow at Baidu as the latter was known for making profits by giving top rankings to unlicensed medical websites which sell unproven drugs.

Qihoo 360 among other media criticized Baidu for its careless control over such matters. However, medical-related ads contributed to a lion’s share (more than 30%) of Baidu’s total revenue, it’s almost impossible for Baidu to drop that large cake at once. That said, in response to outside criticisms, Baidu had taken some steps to put up stronger control over medical scam ads. The rumored tie-up with China’s State FDA is the latest one of a series of such moves.

Start your free trial now.

Get instant access to all our premium content, archives, newsletters, and online community.

Monthly Membership

Yearly Membership

What you get

Full access to all premium content and our full archives

Members'-only newsletters

Preferential access and discounts to all TechNode events

Direct access to the TechNode newsroom

Start your free trial now.

Get instant access to all our premium content, archives, newsletters, and online community.

Monthly Membership

Yearly Membership

Ben Jiang

Listener of startups, writer on tech. Maker of things, dreamer by choice.